INTERNATIONAL PATENT: PROVIREX GENOME EDITING THERAPIES GMBH, PANTHERNA THERAPEUTICS GMBH FILES APPLICATION FOR "LIPID NANOPARTICLES FOR DIRECT DELIVERY"

GENEVA, Jan. 26 -- PROVIREX GENOME EDITING THERAPIES GMBH (c/o Start-up Labs Bahrenfeld Luruper Hauptstr. 122547 Hamburg), PANTHERNA THERAPEUTICS GMBH (Neuendorfstr. 20b16761 Hennigsdorf) filed a patent application (PCT/EP2025/070675) for "LIPID NANOPARTICLES FOR DIRECT DELIVERY" on Jul 18, 2025. With publication no. WO/2026/017865, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FEHRING, Volker (c/o Pantherna Therapeutics GmbHNeuendorfstr. 20b16761 Hennigsdorf), KEIL, Oliver (c/o Pantherna Therapeutics GmbHNeuendorfstr. ...